Yahoo Finance14d
Sobi announces a new research collaboration on the development of Gamifant® (emapalumab) in sepsis, which is to be presented at the ISICEM congress
IDS is a new endotype representing approximately 20 percent of sepsis patients and is characterised by detection of IFNγ (above lower limit of detection) and elevated levels of the chemokine ...
PharmiWeb14d
Sobi announces a new research collaboration on the…
Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...
Contract Pharma14d
Sobi Enters Research Collaboration for Development of Gamifant in Sepsis
Sobi entered a research collaboration involving a new Phase 2a clinical trial for Gamifant (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS). IDS is a new ...
Exchange 4 Media27d
Prasar Bharati signs mega deal with Sudhir Chaudhary to revive Doordarshan
Prasar Bharati has signed a mega deal, possibly its biggest-ever media deal, with veteran editor, journalist and news anchor Sudhir Chaudhary for the much-anticipated revival of Doordarshan.